Statement On Impact Of Audit Qualification
Enclosed is the Statement on Impact of Audit Qualification for the financial year ending March 31, 2018. You are requested to take the same on record.11-06-2018
11-06-2018
Announcement under Regulation 30 (LODR)-Meeting Updates
This is to inform you that there are certain errors in the Audit Report issued by M/s. SHR & Co., Chartered Accountants (FRN : 120491W), Statutory Auditor of the Company submitted with the Stock Exchanges on May 30, 2018 along with the Audited Financial Results of the Company for the quarter and year ended March 31, 2018. You are requested to take the revised Audit Report, as enclosed herewith, on your records.31-05-2018
Board Meeting-Appointment of Director
Appointment of Mr. Balram Singh (DIN : 06918085) as Non-Executive Non-Independent Director of the Company for a term of three years w.e.f May 29, 2018, subject to the approval of shareholders.30-05-2018
Board recommends Dividend
Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2018, inter alia, have recommended Dividend @5% i.e. Re. 0.05 per equity share (Face Value of Re. 1/- each) for the year ended March 31, 2018, subject to the approval of the Shareholders at the ensuing Annual General Meeting.30-05-2018
Board Meeting-Outcome of Board Meeting
The Board of Directors of the Company at its Meeting held on May 29, 2018, which commenced at 8.45 p.m. and concluded at 03.25 p.m. on May 30, 2018, inter alia considered and approved the following : 1. Audited Financial Results for the quarter and year ended March 31, 2018. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015, enclosed is the said results together with the Auditors Report....30-05-2018
Board Meeting-Outcome of Board Meeting
The Board of Directors of the Company at its Meeting held on May 29, 2018, which commenced at 8.45 p.m. and concluded at 03.25 p.m. on May 30, 2018, inter alia considered and approved the following : 1. Audited Financial Results for the quarter and year ended March 31, 2018. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015, enclosed is the said results together with the Auditors Report....30-05-2018
Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-05-2018
Regulation 44(3) Of The SEBI (Listing Obligations And Disclosures Requirements, 2015 --- Details Of The Voting Results Of The Business Transacted At The National Company Law Tribunal (NCLT) Convened General Meeting Of The Equity Shareholders Of The Company.
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we enclose herewith the details regarding the voting results of the business transacted at the NCLT convened Meeting of the Equity Shareholders of the Company held on Monday, 28th May, 2018 at Hotel Parle International, B. N. Agarwal Market, Next to Dinanath Mangeshkar Hall, Vile Parle (East), Mumbai - 400057 in the prescribed format as...30-05-2018
Proceedings Of The National Company Law Tribunal Convened Meeting Of The Equity Shareholders Of The Company Held On Monday, May 28, 2018
Pursuant to the order dated March 21, 2018 passed by the Hon'ble National Company Law Tribunal, Mumbai bench, the Meeting of the Equity Shareholders of the Company was held on May 28, 2018 at 2.30 p.m. at Hotel Parle International, B. N. Agarwal Market, Next to Dinanath Mangeshkar Hall, Vile Parle (East), Mumbai - 400057, Maharashtra, India, to approve Scheme of Amalgamation (Merger by Absorption) of Gufic Stridden Bio-Pharma Private Limited(Transferor...29-05-2018